All ongoing clinical trials for the EU must be transitioned to the Clinical Trial Information System (CTIS), which completely replaces EudraCT on January 31, 2025. We strongly advise not to wait until the last minute for the transition.
Gaining elaborate expertise in recent years and months, we would be glad to support you with the transition to CTIS. Since 2016, we have been involved as a stakeholder representing EUFEMED in a User Acceptance Testing organized by EMA, obtaining intensive practical experience with the European database. Through successful participation in the EMA CTIS Master Program, we enhanced our knowledge by interactively working on challenges, gaining insights, and actively shaping the transition process.
Please let us know if we can assist with your transition and contact us here.
You can find more details of a successful transition here on our LinkedIn page.